← FDA Drug Approvals (Drugs@FDA)
IBANDRONATE SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NANG KUANG PHARM CO · Approved 2021-06-16
Drug application
- FDA Application #
ANDA204329- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IBANDRONATE SODIUM
- Generic name
- Ibandronate Sodium
- Active ingredients
- IBANDRONATE SODIUM
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Discontinued
- Sponsor
- NANG KUANG PHARM CO
- First approval
- 2021-06-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown